Dividend Overview
Dividend Yield
—
Dividend / Share
—
Xenon Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.
Current Price
$54.12
-1.02%Profile
Valuation (TTM)
Market Cap$4.50B
P/E-11.75
EV—
P/B7.74
Shares Out83.19M
P/Sales—
Revenue$0.00
EV/EBITDA—
Xenon Pharmaceuticals Inc (XENE) Dividends
Key Metrics
Market Cap
$4.50B
P/E Ratio
-11.75
Forward P/E
—
EPS
$-4.36
PEG Ratio
-0.29
Book Value
$6.99
Dividend Yield
—
Profit Margin
—
ROE
-65.86%
Dividend History
Dividend Safety
XENE Dividend Analysis
Xenon Pharmaceuticals Inc (XENE) dividend analysis including yield, payout history, and sustainability metrics.
P/E ratio: -11.75. Free cash flow: $-279.92M. This page shows Xenon Pharmaceuticals Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Xenon Pharmaceuticals Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.